Will Palpal exceed Cialis? The industry has paid attention on impotence treatments
The industry concerned paid attention on the Palpal’s (Hanmi Pharmaceutical) direction to exceed over the top impotence treatment ‘Cialis’.
In various indexes, there is higher possibility Palpalwill take the lead. The patent expiration of Cialis on September can be a chance to Palpal.
According...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
